Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -8.37%-816M | -116.16%-753M | 185.08%4.66B | -27.78%1.64B | -39.64%2.26B | 38.87%3.75B | 73.70%2.7B | -64.13%1.56B | 1,281.20%4.34B | 4.43%-367M |
Net profit before non-cash adjustment | -93.78%-2.31B | -237.25%-1.19B | -47.36%867M | -34.95%1.65B | 17.77%2.53B | 26.10%2.15B | 54.86%1.71B | -47.77%1.1B | -45.78%2.11B | -60.72%3.89B |
Total adjustment of non-cash items | 111.77%1.64B | 0.65%773M | -43.15%768M | -1.03%1.35B | -17.42%1.37B | 65.30%1.65B | 16.14%1B | -10.87%861M | 65.41%966M | 112.31%584M |
-Depreciation and amortization | 4.55%1.29B | -10.79%1.23B | 4.46%1.38B | 0.92%1.32B | 10.55%1.31B | 11.06%1.19B | 1.14%1.07B | 11.40%1.06B | 4.99%947M | 9.20%902M |
-Reversal of impairment losses recognized in profit and loss | 641.04%1.86B | --251M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Disposal profit | -274.93%-1.33B | 15.27%-355M | -373.86%-419M | -36.51%153M | -62.28%241M | 441.53%639M | 176.62%118M | -1,640.00%-154M | 122.22%10M | -113.47%-45M |
-Net exchange gains and losses | 90.43%-22M | -150.00%-230M | -1,214.29%-92M | -133.33%-7M | 250.00%21M | 44.00%-14M | -151.02%-25M | -15.52%49M | 132.95%58M | -402.86%-176M |
-Other non-cash items | -26.40%-158M | -22.55%-125M | 12.82%-102M | 43.48%-117M | -31.85%-207M | 1.88%-157M | -79.78%-160M | -81.63%-89M | 49.48%-49M | 98.35%-97M |
Changes in working capital | 56.51%-147M | -111.18%-338M | 321.95%3.02B | 16.54%-1.36B | -2,922.22%-1.63B | -1,700.00%-54M | 99.26%-3M | -132.33%-407M | 126.03%1.26B | 12.66%-4.84B |
-Change in receivables | 287.38%2.08B | -113.73%-1.11B | 686.07%8.08B | -31.74%-1.38B | -144.96%-1.05B | -179.37%-427M | 233.83%538M | -124.77%-402M | 9,116.67%1.62B | 99.40%-18M |
-Change in inventory | -285.54%-603M | 128.16%325M | -274.58%-1.15B | 5.93%661M | 4.70%624M | 131.52%596M | -1,186.78%-1.89B | -93.92%174M | 249.04%2.86B | -40.84%-1.92B |
-Change in payables | -358.81%-823M | 109.38%318M | -1,184.09%-3.39B | 72.30%-264M | 26.35%-953M | -173.90%-1.29B | 823.55%1.75B | 89.58%-242M | -1,299.40%-2.32B | -116.16%-166M |
-Provision for loans, leases and other losses | 165.98%64M | 25.38%-97M | -2,700.00%-130M | 105.10%5M | -122.95%-98M | 214.48%427M | -1,056.41%-373M | -67.23%39M | 145.77%119M | 84.73%-260M |
-Changes in other current assets | -731.17%-972M | -42.11%154M | 143.97%266M | -174.42%-605M | 4,882.35%813M | 92.61%-17M | -162.67%-230M | 131.34%367M | 44.50%-1.17B | -392.99%-2.11B |
-Changes in other current liabilities | 53.52%109M | 111.01%71M | -394.52%-645M | 122.53%219M | -247.05%-972M | 227.23%661M | 158.89%202M | -331.76%-343M | 141.00%148M | -446.97%-361M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 38.46%-40M | -80.56%-65M | -28.57%-36M | -12.00%-28M | -56.25%-25M | 0.00%-16M | 66.67%-16M | -17.07%-48M | -13.89%-41M | -176.92%-36M |
Interest received (cash flow from operating activities) | -16.41%163M | 8.33%195M | 0.00%180M | -18.18%180M | 22.22%220M | -0.55%180M | 33.09%181M | -2.86%136M | 5.26%140M | 13.68%133M |
Tax refund paid | 75.61%-60M | 61.50%-246M | -88.50%-639M | 62.95%-339M | -23.98%-915M | -57.69%-738M | 31.88%-468M | 41.03%-687M | -31.34%-1.17B | 35.91%-887M |
Other operating cash inflow (outflow) | 0.00%-1M | -1M | 0 | 0.00%-1M | -1M | 0 | 0 | 0 | -1M | 0 |
Operating cash flow | 13.33%-754M | -120.88%-870M | 187.91%4.17B | -6.22%1.45B | -51.43%1.54B | 32.49%3.18B | 150.84%2.4B | -70.75%956M | 382.45%3.27B | 30.47%-1.16B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 181.11%614M | 45.77%-757M | -20.14%-1.4B | 35.91%-1.16B | -67.41%-1.81B | 11.23%-1.08B | 4.09%-1.22B | -39.47%-1.27B | -2.82%-912M | 23.73%-887M |
Net business purchase and sale | ---950M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net investment product transactions | 232.80%4.18B | -69.16%1.26B | 1,818.14%4.07B | -131.64%-237M | 574.77%749M | 104.76%111M | 58.44%-2.33B | -454.39%-5.62B | -121.18%-1.01B | 491.65%4.78B |
Advance cash and loans provided to other parties | ---1M | --0 | --0 | 98.51%-3M | -142.17%-201M | ---83M | --0 | 97.14%-1M | 45.31%-35M | 33.33%-64M |
Repayment of advance payments to other parties and cash income from loans | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | -91.67%1M | --12M | ---- | -97.94%2M | 9,600.00%97M | -96.88%1M |
Net changes in other investments | 733.33%19M | -200.00%-3M | 400.00%3M | -133.33%-1M | 103.90%3M | -37.50%-77M | -5,500.00%-56M | 98.21%-1M | -3.70%-56M | 83.13%-54M |
Investing cash flow | 677.26%3.86B | -81.46%497M | 291.16%2.68B | -11.18%-1.4B | -12.59%-1.26B | 68.98%-1.12B | 47.59%-3.61B | -258.94%-6.89B | -150.79%-1.92B | 236.49%3.78B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -38.05%1.84B | 1,490.61%2.96B | -914.29%-213M | -110.19%-21M | 984.21%206M | 103.78%19M | 24.25%-503M | -258.10%-664M | -15.15%420M | 468.97%495M |
Net common stock issuance | -134.18%-1.75B | 75.88%-749M | -62,200.00%-3.11B | 100.81%5M | -15,275.00%-615M | 60.00%-4M | 92.65%-10M | 71.19%-136M | 44.14%-472M | 14.65%-845M |
Increase or decrease of lease financing | 8.70%-63M | -2.99%-69M | 5.63%-67M | -9.23%-71M | -242.11%-65M | 13.64%-19M | 8.33%-22M | 17.24%-24M | 21.62%-29M | 15.91%-37M |
Cash dividends paid | 40.19%-616M | -89.69%-1.03B | 0.37%-543M | 1.80%-545M | -0.18%-555M | 39.52%-554M | 0.97%-916M | 1.18%-925M | 2.60%-936M | -60.70%-961M |
Cash dividends for minorities | 2.29%-171M | 16.27%-175M | ---209M | --0 | 37.88%-41M | -24.53%-66M | -29.27%-53M | -86.36%-41M | -15.79%-22M | 5.00%-19M |
Net other fund-raising expenses | -102.70%-1M | 1,950.00%37M | -100.00%-2M | -200.00%-1M | 150.00%1M | 0.00%-2M | 33.33%-2M | -200.00%-3M | 0.00%-1M | ---1M |
Financing cash flow | -178.89%-770M | 123.58%976M | -553.87%-4.14B | 40.79%-633M | -70.77%-1.07B | 58.43%-626M | 16.01%-1.51B | -72.40%-1.79B | 23.98%-1.04B | 12.59%-1.37B |
Net cash flow | ||||||||||
Beginning cash position | 8.47%14.25B | 27.57%13.14B | -5.77%10.3B | -4.90%10.93B | 14.19%11.49B | -21.16%10.07B | -36.92%12.77B | 0.15%20.24B | 7.65%20.21B | -23.69%18.77B |
Current changes in cash | 287.89%2.34B | -77.72%603M | 560.37%2.71B | 25.29%-588M | -155.00%-787M | 152.65%1.43B | 64.82%-2.72B | -2,600.00%-7.73B | -75.34%309M | 120.89%1.25B |
Effect of exchange rate changes | -56.30%222M | 284.85%508M | 406.98%132M | -714.29%-43M | 450.00%7M | -113.33%-2M | 153.57%15M | 89.86%-28M | -251.65%-276M | 7.06%182M |
Cash adjustments other than cash changes | 25,700.00%516M | 100.00%2M | --1M | ---- | 21,800.00%217M | -200.00%-1M | -99.64%1M | 14,100.00%280M | -300.00%-2M | --1M |
End cash Position | 21.59%17.33B | 8.47%14.25B | 27.57%13.14B | -5.77%10.3B | -4.90%10.93B | 14.19%11.49B | -21.16%10.07B | -36.92%12.77B | 0.15%20.24B | 7.65%20.21B |
Free cash flow | -20.21%-1.97B | -159.39%-1.64B | 960.77%2.76B | 190.28%260M | -113.77%-288M | 81.28%2.09B | 453.99%1.15B | -114.26%-326M | 211.46%2.29B | 27.73%-2.05B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |